| Literature DB >> 33214632 |
Haijiao Mao1, Haiqing Wang2, Jiyuan Zhao3, Linger Wang4, Liwei Yao4, Ke Wei5.
Abstract
The purpose of this study was to provide an initial assessment of treatment for talar posterior process fractures using open reduction and internal fixation (ORIF) through posteromedial approach and percutaneous screw fixation. From January 2014 to December 2018, 12 cases with displaced fracture of talar posterior process were treated in our department. The clinical and radiological results were assessed after 4 and 12 months of operation with Visual Analog Scale (VAS) pain and American Orthopedic Foot and Ankle Society (AOFAS) scores. ORIF was performed in four of the cases and percutaneous screw fixation was performed in eight of the cases. The average follow-up period was 13 months. Complications such as wound infection, nerve injury, screw loosening, malunion or nonunion of fracture were absent. For clinical assessment, considerable mprovements were observed for the AOFAS and VAS scores at 4 and 12 months postoperatively for both techniques. There was no significant difference for AOFAS scores and VAS scores between the two techniques (p > 0.05). Both techniques showed good functional outcome and were performed for posterior talar process fracture following the fracture displacement guidelines. Percutaneous screw fixation treatment with computer-assisted three-dimensional evaluation shortened the operation time and reduced incidences of surgical complications.Entities:
Mesh:
Year: 2020 PMID: 33214632 PMCID: PMC7678821 DOI: 10.1038/s41598-020-77151-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Comparison AOFAS scores (Group1 = 4; Group = 8).
| AOFAS scores | Group 1 | Group 2 | ||
|---|---|---|---|---|
| Preoperative | 64.5 ± 1.73 | 63.5 ± 2.07 | 0.774 | > 0.05 |
| 4 months postoperatively | 83. 5 ± 1.00 | 84.1 ± 1.80 | 0.364 | > 0.05 |
| 12 months postoperatively | 82.3 ± 0.96 | 83.9 ± 1.24 | 1.058 | > 0.05 |
The p-values were determined using Mann Whitney U test. Significance levels are one symbol: p < 0.05.
Non-significant difference between preoperative AOFAS scores in group 1 and group 2.
Non-significant difference of AOFAS scores group 1 and group 2 after 4 months.
Non-significant difference of AOFAS scores in group 1 and group 2 after 12 months.
Comparison VAS scores (Group1 = 4; female = 8).
| VAS scores | Group 1 | Group 2 | Z | |
|---|---|---|---|---|
| Preoperative | 4.5 ± 1.00 | 5.25 ± 0.88 | 0.573 | > 0.05 |
| 4 months postoperatively | 2.0 ± 0.82 | 2.3 ± 0.46 | 0.612 | > 0.05 |
| 12 months postoperatively | 1.8 ± 0.50 | 1.5 ± 0.53 | 0.793 | > 0.05 |
The p-values were determined using independent sample t-test. Significance levels are one symbol: p < 0.05.
Non-significant difference between preoperative VAS scores e in group 1 and group 2.
Non-significant difference of VAS scores in group 1 and group 2 after 4 months.
Non-significant difference of VAS scores in group 1 and group 2 after 12 months.
Comparison different time (Group1) (n = 4).
| AOFAS | VAS | |
|---|---|---|
| Preoperative | 64.5 ± 1.73 | 4.5 ± 1.00 |
| 4 months postoperatively | 83. 5 ± 1.00 | 2.0 ± 0.82 |
| 12 months postoperatively | 82.3 ± 0.96 | 1.8 ± 0.50 |
| F | 282.59 | 14.478 |
| < 0.05 | < 0.05 | |
| < 0.05 | < 0.05 | |
| < 0.05 | < 0.05 | |
| 0.429 | 0.669 |
pa compare the results between preoperative with 4 months postoperatively .
pb compare the results between preoperative with 12 months postoperatively.
pc compare the results between 4 months with 12 months postoperatively.
Comparison different time (Group 2) (n = 8).
| AOFAS | VAS | |
|---|---|---|
| Preoperative | 63.5 ± 2.07 | 5.25 ± 0.88 |
| 4 months postoperatively | 84.1 ± 1.80 | 2.3 ± 0.46 |
| 12 months postoperatively | 83.9 ± 1.24 | 1.5 ± 0.53 |
| F | 369.202 | 73.50 |
| < 0.05 | < 0.05 | |
| < 0.05 | < 0.05 | |
| < 0.05 | < 0.05 | |
| 0.777 | 0.032 |
pa compare the results between preoperative with 4 months postoperatively.
pb compare the results between preoperative with 12 months postoperatively.
pc compare the results between 4 months with 12 months postoperatively.
Figure 1The 3D model with medial and lateral virtual screw path of the posterior talar process. (A) Lateral tubercle of posterior talar process; (B) medial tubercle of posterior talar process; (C) groove of the flexor hallucis longus tendon.
Figure 2Cadaver specimen with tibial neurovascular bundle accompanied with the FHL tendon, which is located at the level of the posterior ankle joint. (A) Flexor hallucis longus tendon; (B) posterior tibial artery; (C) plantar nerve.
Figure 3Cadaver specimen with posterior ankle joint and posterior talar process. (A) Lateral tubercle of posterior talar process; (B) medial tubercle of posterior talar process; (C) groove of the flexor hallucis longus tendon; (D) posterior talofibular ligament; (E) calcaneofibular ligament.
Figure 4Intraoperative photo of ORIF. The yellow arrow is a cannulated screw. The blue arrow is the flexor hallucis longus tendon.
Figure 5Intraoperative photo of percutaneous screw implanted with the minimally invasive technique. (A) Medial ankle; (B) achilles tendon; (C) entry point of percutaneous screw.
Figure 6Intraoperative fluoroscopy photo of percutaneous screw implanted with the minimally invasive technique.
Figure 7Axial view of CT scans showing that the internal fixation was performed properly.